HCC Member

Xinhui Wang, MD, PhD

Massachusetts General Hospital

Academic Titles
Associate Professor, Surgery, Harvard Medical School
Research Program Affiliation
Member, Cancer Immunology
Member, Angiogenesis, Invasion and Metastasis
Research Abstract

My laboratory is focused on targeting cancer stem cells in the context of radiation and chemotherapy by repurposing the FDA-approved drug for treatment of alcohol dependence, disulfiram for breast cancer, pancreatic ductal carcinoma, chordoma and sarcoma. In addition, my laboratory is interested in developing immunotherapies for solid tumors with personalized tumor vaccines and chimeric antigen receptor (CAR)-T cell therapy.